In breast, colorectal, and prostate cancers, PRMT4, 5, and 7 were upregulated and associated with high levels of arginine methylation on their-regulated methylome, such as hnRNPA1, and aberrant gene alternative splicing, thereby potentially driving cancer cell growth (Fig. 8m). This evidence concerns the gene HNRNPA1 and prostate cancer.